Vera Therapeutics, Inc. (VERA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $130.21M | +65.8% |
| 2024 | $78.53M | +6.3% |
| 2023 | $73.86M | +35.5% |
| 2022 | $54.53M | +285.2% |
| 2021 | $14.16M | +227.2% |
| 2020 | $4.33M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $130.21M | +65.8% |
| 2024 | $78.53M | +6.3% |
| 2023 | $73.86M | +35.5% |
| 2022 | $54.53M | +285.2% |
| 2021 | $14.16M | +227.2% |
| 2020 | $4.33M | — |